LDN Video Interviews and Presentations

Chronic diseases can be difficult to manage, but there are ways to improve your quality of life. Dr. Sarah Zielsdorf, who serves as the medical advisor and education director of the LDN Research Trust, is a great resource for understanding chronic disease management. Her expertise can help you navigate the complexities of chronic illnesses and develop a personalized plan for managing your symptoms. Whether you're dealing with autoimmune diseases, chronic pain conditions, or other long-term health issues, Dr. Zielsdorf's insights can be invaluable in helping you live your best life. 

Melanie, a resident of Canada, went through a challenging journey of coping with multiple health conditions such as MCAS, POTS, Sjogren’s, Fibromyalgia, Asthma, and Hashimoto's. It's undoubtedly difficult to manage so many health issues simultaneously. However, Melanie found that once she was diagnosed with MCAS and learned how to control it, she observed an improvement in every other condition she had. It's admirable how she persevered through her struggles and learned to manage her health issues effectively. 

Tracy from the United States, has bravely shared her personal experience dealing with three intricate medical conditions: Postural Orthostatic Tachycardia Syndrome (POTS), Mast Cell Activation Syndrome (MCAS), and Hypermobile Ehlers-Danlos Syndrome (hEDS). Her story is an eye-opener for many as these conditions are often misunderstood and difficult to diagnose. Tracy's account provides important insights into the challenges faced by individuals living with these complex health issues. 

Today, I had an insightful conversation with Michelle, a physician assistant, who recently opened her own integrative health practice. Michelle focuses on optimizing her patients' health and treating each person uniquely, addressing issues such as sleep quality, thyroid function, and hormone balance. She also prescribes LDN (Low Dose Naltrexone) for many of her patients and has seen positive results in improving their overall well-being. Her approach to personalized care and empowering patients in decision-making has been rewarding and successful. 

 Natalie from the US shares her Eds (hypermobile syndrome), pots, monoclonal mast disease experience with US. .

This interview offers a detailed and introspective look into Mandi's journey with LDN, thoracic outlet syndrome, MCAS, POTS and EDS. Through her account, she delves into the intricacies of her diagnosis, the complexities of surgical interventions, and the impact of her children's medical challenges on her own health journey. Additionally, Mandi provides an in-depth exploration of how LDN has played a pivotal role in managing these intricate conditions, offering a comprehensive and informative perspective. 

Living with the chronic conditions of Mast Cell Activation Syndrome (MCAS), Postural Orthostatic Tachycardia Syndrome (POTS), hypermobile Ehlers-Danlos Syndrome (hEDS), Polycystic Ovary Syndrome (PCOS), and Sjogren's Syndrome can be extremely challenging. Lindsay, who lives with these conditions, must face numerous daily struggles and triumphs. Despite her difficulties, Lindsay's determination and resilience continue to inspire others. It is noteworthy that she is not only a patient but also a Registered Nurse (RN) and Licensed Professional Counselor (LPC). Her experience as a healthcare professional and a patient make her an excellent example of strength and courage. 

Welcome to the LDN Radio Show hosted by Linda Elsegood, sponsored by the LDN Research Trust. The show features expert discussions on Low Dose Naltrexone (LDN) and its applications in treating autoimmune diseases and cancer. Today's guest, Shelly from Florida, shares her experience with multiple sclerosis (MS) and her journey with LDN. Shelly, diagnosed with MS years ago, transitioned to secondary progressive MS. Despite trying various treatments, severe pain from bulging discs led her to discover LDN. Within six weeks of starting LDN, her debilitating pain vanished, drastically improving her quality of life.

Shelly recounts her initial MS symptoms, such as optic neuritis, which led to her diagnosis. She discusses the significant impact of her diet changes, eliminating gluten, dairy, and sugar, which alleviated many MS symptoms like drop foot, vertigo, and migraines. Shelly emphasizes the importance of clean eating and a disciplined supplement regimen, which includes vitamins, minerals, and natural substances. Her story highlights the potential of LDN and dietary management in improving MS symptoms and overall well-being. The show concludes with an invitation for listeners to reach out with questions, underscoring the support and information the LDN Research Trust provides.

In a recent episode of the LDN Radio Show hosted by Linda Elsegood of the LDN Research Trust, guest speaker Kara from the United States shared her personal journey using Low-Dose Naltrexone (LDN) to manage multiple sclerosis (MS). Kara recounted her initial MS symptoms during her university years, including recurrent UTIs and muscle spasms, and described a severe episode of trigeminal neuralgia that led to her diagnosis. She revealed that her MRI not only confirmed MS but also detected early-stage thyroid cancer, which was successfully treated.

As a lawyer and wife of a physician, Kara utilized her resources to educate herself on the benefits of LDN, ultimately choosing it over traditional disease-modifying therapies. Her experience with LDN has been transformative, significantly improving her balance, reducing fatigue, and eliminating UTIs. Kara also noted the vivid dreams as the only side effect and emphasized the drug's positive impact on her overall health and inflammatory markers.

Kara's testimony highlights the potential of LDN as an immune-modulating therapy with minimal side effects, advocating its use for others with MS. Her story underscores the importance of exploring LDN as a viable treatment option and maintaining an open mind towards alternative therapies for autoimmune conditions.

Miriam Martinez Callejas is the Superintendent Pharmacist and co-founder of Roseway Labs. During her master’s degree in Pharmacy, she trained in formulating medication and her first job was in a compounding pharmacy in Spain. There, she developed a passion for helping others using her experience and knowledge of medicine.

At Roseway Labs, both prescribers and patients benefit from the formulations and compounding expertise that Miriam has developed over the past 20 years. She develops new formulations, finds ways to meet complex patient needs and trains practitioners to prescribe compounded medications. In demand as a conference speaker, she has participated in many sessions including at Menopause in Aesthetics, Aesthetics Medicine Live, Integrative and Personalised Medicine Congress, LDN Conference and BAHRS.

As Superintendent Pharmacist, Miriam is responsible for ensuring that Roseway Labs operates in compliance with General Pharmaceutical Council regulations pertaining to the safe and effective provision of pharmacy and compounding services.